📰 Roberte Hoffman News
Page 2 - Roberte Hoffman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roberte Hoffman. Real-time updates on events, politics, business and more.
September 8, 2023
Antibe Therapeutics Inc. , a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation therapies to target inflammation, is pleased to announce the results of its...
August 9, 2023
SAN DIEGO, Aug. 9, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President...
July 19, 2023
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
June 28, 2023
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
June 16, 2023
SAN DIEGO, June 16, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its... | June 16, 2023
May 19, 2023
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
May 17, 2023
Robert E. Hoffman, Jr. was born on October 26, 1955, to Robert E Hoffman, Sr. and Lula M. Hoffman in Mexico. Robert grew his wings on Wednesday, May 3, 2023, in his family home. Funeral Services …
May 11, 2023
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
May 8, 2023
SAN DIEGO, May 8, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its... | May 8, 2023
May 1, 2023
SAN DIEGO, May 1, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its... | May 1, 2023